Development and validation of indigenously developed mobile-Health diagnostic devices for real-time quantification of: Cardiac Troponin T, Lp-PLA2, Glucose, Insulin, HIV p24 antigen, Triiodothyronine, Thyroxine and Thyroid-Stimulating Hormone
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 400
- 试验地点
- 2
- 主要终点
- Understand thyroid dysfunction in fluoride endemic areas.
研究概览
简要总结
The present study would lead to a betterunderstanding of Hypo/hyperthyroidism, especially in fluoride endemic areas,assess clinical outcomes for patients with ACS thus facilitating early diagnosis and managementof these diseases. We also intend to develop a portable, hand-heldmedical diagnostic device that will be capable of diagnosis of these diseases.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with known or suspected thyroid abnormalities and skeletal fluorosis.
- •For the patients with acute coronary syndrome, inclusion age is 18 and above, both males and females.
排除标准
- •Patients below the age of 6 years and pregnant woman are excluded for thyroid study.
- •Patients identified with Hashimoto thyroiditis will also be excluded from the thyroid study.
- •For heart study, patients with renal failure will be excluded.
结局指标
主要结局
Understand thyroid dysfunction in fluoride endemic areas.
时间窗: For thyroid study, from the date of enrollment, sampling will be done once every 3 months, four times during the year. | For the heart study, sampling will be done four times - at the time of admission, at discharge, 1st and 6th month after the medical intervention.
Understand nexus between depression and cardiac function.
时间窗: For thyroid study, from the date of enrollment, sampling will be done once every 3 months, four times during the year. | For the heart study, sampling will be done four times - at the time of admission, at discharge, 1st and 6th month after the medical intervention.
次要结局
- Hand-held device for disease diagnosis(4 years)